ABSK131

· Abbisko Therapeutics Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABSK131, covering 2025-12-17 to 2025-12-17. Get the full timeline:

Most recent: Clinical Trial Update: A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors [Phase 1]